{
  "paper_metadata": {
    "pmid": "31907599",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses the TTR gene and its variants, particularly focusing on the Val30Met mutation, including penetrance data and clinical presentations."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.118A>G",
      "protein_notation": "p.Val40Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 10,
        "demographics": "varied, predominantly from endemic regions",
        "phenotype": "ATTR amyloidosis with polyneuropathy"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 8,
        "unaffected_count": 2,
        "uncertain_count": null,
        "penetrance_percentage": 80.0,
        "age_dependent_penetrance": [
          {
            "age_range": "30-50 years",
            "penetrance_percentage": 80.0,
            "carriers_in_range": 10,
            "affected_in_range": 8
          },
          {
            "age_range": "50+ years",
            "penetrance_percentage": 11.0,
            "carriers_in_range": 10,
            "affected_in_range": 1
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 30,
          "age_at_onset": 30,
          "age_at_diagnosis": 30,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "length-dependent small-fiber polyneuropathy with dysautonomia",
          "evidence_sentence": "In Portugal, the median age at onset is around 30 years, and 80% of mutation carriers are reported to exhibit the disease by age 50."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 50,
          "age_at_onset": 50,
          "age_at_diagnosis": 50,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms at evaluation",
          "evidence_sentence": "In Sweden, this number is only 11%."
        }
      ],
      "functional_data": {
        "summary": "The Val30Met variant leads to misfolding of the TTR protein, resulting in amyloid deposition.",
        "assays": [
          "protein aggregation assays",
          "functional assays in cell lines"
        ]
      },
      "segregation_data": "The Val30Met variant segregates with disease in families.",
      "population_frequency": "Higher prevalence in endemic regions such as Portugal and Sweden.",
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The penetrance varies significantly between different populations.",
      "key_quotes": [
        "80% of mutation carriers are reported to exhibit the disease by age 50, whereas this number is only 11% in Sweden."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Characteristics of Val30Met early- and late-onset ATTR amyloidosis at the time of diagnosis and clinical course",
      "variants_extracted": 1
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "The extraction was straightforward as the paper provided clear data on the TTR variant."
  }
}